AADACL3 | Arylacetamide deacetylase-like 3 | | | | | | Group enriched |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
ARMS2 | Age-related maculopathy susceptibility 2 | Disease related genes Mitochondrial proteins
| | | | | Group enriched |
CHRM5 | Cholinergic receptor, muscarinic 5 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | | | | Group enriched |
IGF2 | Insulin-like growth factor 2 (somatomedin A) | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
OLAH | Oleoyl-ACP hydrolase | Enzymes
| | | | | Group enriched |
PRG2 | Proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC6A4 | Solute carrier family 6 (neurotransmitter transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CAPN6 | Calpain 6 | Cancer-related genes Enzymes
| | | | | Tissue enriched |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
ELOVL2 | ELOVL fatty acid elongase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
GDPD4 | Glycerophosphodiester phosphodiesterase domain containing 4 | Predicted membrane proteins
| | | | | Group enriched |
GPR78 | G protein-coupled receptor 78 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
IDO2 | Indoleamine 2,3-dioxygenase 2 | | | | | | Group enriched |
TMEM40 | Transmembrane protein 40 | Predicted membrane proteins
| | | | | Group enriched |
CADM3 | Cell adhesion molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CTSV | Cathepsin V | Enzymes Predicted secreted proteins
| | | | | Group enriched |
DLX4 | Distal-less homeobox 4 | Transcription factors
| | | | | Tissue enriched |
DLX5 | Distal-less homeobox 5 | Disease related genes Transcription factors
| | | | | Group enriched |
DLX6 | Distal-less homeobox 6 | Transcription factors
| | | | | Group enriched |
EPYC | Epiphycan | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
GABRA4 | Gamma-aminobutyric acid (GABA) A receptor, alpha 4 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
GPC3 | Glypican 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KRT23 | Keratin 23 (histone deacetylase inducible) | | | | | | Group enriched |
MEST | Mesoderm specific transcript | Predicted secreted proteins
| | | | | Tissue enriched |
PAGE4 | P antigen family, member 4 (prostate associated) | Cancer-related genes
| | | | | Tissue enriched |
SERPINB2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC30A2 | Solute carrier family 30 (zinc transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SVEP1 | Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | Predicted secreted proteins
| | | | | Group enriched |
TBX5 | T-box 5 | Disease related genes Transcription factors
| | | | | Group enriched |
TRAPPC3L | Trafficking protein particle complex 3-like | | | | | | Group enriched |
WNT2 | Wingless-type MMTV integration site family member 2 | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
WNT3A | Wingless-type MMTV integration site family, member 3A | Predicted secreted proteins
| | | | | Group enriched |
ATP6V1C2 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 | Transporters
| | | | | Group enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | | | Group enriched |
CORO6 | Coronin 6 | | | | | | Group enriched |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
GDF6 | Growth differentiation factor 6 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
L1TD1 | LINE-1 type transposase domain containing 1 | | | | | | Group enriched |
MAGEA10 | Melanoma antigen family A, 10 | | | | | | Tissue enriched |
RGPD1 | RANBP2-like and GRIP domain containing 1 | | | | | | Group enriched |
SH2D5 | SH2 domain containing 5 | | | | | | Group enriched |
TCTEX1D1 | Tctex1 domain containing 1 | | | | | | Group enriched |
ZIM2 | Zinc finger, imprinted 2 | Transcription factors
| | | | | Group enriched |
AC110619.2 | Uncharacterized protein | | | | | | Tissue enhanced |
ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |